Aurora Spine recorded $4.5 million in revenue during the second quarter of 2025, according to an Aug. 29 news release from the company.
Here are eight more notes on the company’s second quarter:
- The $4.5 million in revenue represents a 10.2% increase over the same quarter last year, when the company had $4.1 million in revenue.
- The bump in revenue was driven by more procedures being conducted in ambulatory surgery and pain centers that utilized Aurora technology.
- Aurora Spine’s Ortho/Neuro surgical market saw a decrease in sales caused by lower lumbar cage sales.
- The company has refocused on the cervical spine market, bringing in $794,000 in cervical sales in 2025 so far, compared to $467,000 in cervical sales during the first half of 2024.
- Net loss for the second quarter was $0.2 million.
- The company’s 2025 second quarter EBITDAC was $141,745.
- Aurora Spine recorded $2.97 million in total operating expenses during the second quarter.
- In the second quarter, Aurora Spine surpassed 2,500 completed procedures with the SiLO Joint Fusion System and 1,500 surgeries using DEXA-C.
